Showing results (221-230 of 389) with videos related to
Sort By:
Pageof 39
European Journal of Cancer (Oxford, England : 1990)|April 4, 2021
Osimertinib versus osimertinib plus chemotherapy for non-small cell lung cancer with EGFR (T790M)-associated resistance to initial EGFR inhibitor treatment: An open-label, randomised phase 2 clinical trialKentaro Tanaka, Hajime Asahina, Junji Kishimoto, et al.International Journal of Cancer|May 2, 2020
Predictive and prognostic impact of primary tumor-bearing lobe in nonsmall cell lung cancer patients treated with anti-PD-1 therapyShinkichi Takamori, Kazuki Takada, Mototsugu Shimokawa, et al.Cancer Chemotherapy and Pharmacology|November 13, 2015
Phase I study of nintedanib in combination with pemetrexed as second-line treatment of Japanese patients with advanced non-small cell lung cancerHaruko Daga, Koji Takeda, Hideaki Okada, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 11, 2011
Phase I clinical study of the angiogenesis inhibitor TSU-68 combined with carboplatin and paclitaxel in chemotherapy-naive patients with advanced non-small cell lung cancerIsamu Okamoto, Hiroshige Yoshioka, Koji Takeda, et al.Anticancer Research|December 11, 2013
Phase I pharmacokinetic study of S-1 granules and nedaplatin for advanced head and neck cancerHidetoshi Hayashi, Isamu Okamoto, Shinya Ueda, et al.Journal of Cancer Research and Clinical Oncology|February 7, 2020
Clinical impact of skeletal muscle area in patients with non-small cell lung cancer treated with anti-PD-1 inhibitorsKazuki Takada, Yasuto Yoneshima, Kentaro Tanaka, et al.Clinical Lung Cancer|March 26, 2017
Treatment Rationale and Design for J-AXEL: A Randomized Phase 3 Study Comparing Nab-Paclitaxel With Docetaxel in Patients With Previously Treated Advanced Non-Small-Cell Lung CancerYasuto Yoneshima, Satoshi Morita, Masahiko Ando, et al.Cancer Medicine|January 10, 2014
Human papillomavirus DNA and p16 expression in Japanese patients with oropharyngeal squamous cell carcinomaHisato Kawakami, Isamu Okamoto, Kyoichi Terao, et al.In Vivo (Athens, Greece)|October 24, 2018
Radiological Features of Programmed Cell Death-Ligand 2-positive Lung Adenocarcinoma: A Single-institution Retrospective StudyKazuki Takada, Gouji Toyokawa, Koichi Azuma, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 23, 2015
Heterogeneity of anaplastic lymphoma kinase gene rearrangement in non-small-cell lung carcinomas: a comparative study between small biopsy and excision samplesHideyuki Abe, Akihiko Kawahara, Koichi Azuma, et al.Pageof 39